RAPP
NASDAQ · Pharmaceuticals
Rapport Therapeutics Inc
$40.45
-1.50 (-3.58%)
Open$41.89
Previous Close$41.95
Day High$43.00
Day Low$40.29
52W High$52.93
52W Low$23.75
Volume—
Avg Volume322.6K
Market Cap2.00B
P/E Ratio—
EPS$-3.04
SectorPharmaceuticals
Analyst Ratings
Strong Buy
19 analysts
Price Target
+11.7% upside
Current
$40.45
$40.45
Target
$45.18
$45.18
$32.24
$45.18 avg
$61.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 234.18M | 211.21M | 206.84M |
| Net Income | 54.92M | 48.45M | 43.47M |
| Profit Margin | 23.5% | 22.9% | 21.0% |
| EBITDA | 80.71M | 80.88M | 78.48M |
| Free Cash Flow | 32.46M | 39.08M | 24.42M |
| Rev Growth | +10.7% | -0.4% | +18.1% |
| Debt/Equity | 0.72 | 0.64 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |